SGH
BIIB icon

Schonfeld Group Holdings’s Biogen BIIB Stock Holding History

Schonfeld Group Holdings’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$715K Buy
2,334
+834
+56% +$240K 0.45% 62
2015
Q3 		$438K Buy
+1,500
New +$495K 0.23% 84
2014
Q2 		– Sell
-4,700
Closed -$1.44M – 64
2014
Q1 		$1.44M Buy
4,700
+2,599
+124% +$825K 0.36% 57
2013
Q4 		$587K Buy
+2,101
New +$543K 0.22% 111

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Schonfeld Group Holdings's BIIB Position: Q4 2015 in Review

Schonfeld Group Holdings increased its Biogen (BIIB) stake by 56% in Q4 2015, buying an estimated $240K and bringing the position to 2,334 shares worth $715K. The position accounts for 0.45% of the portfolio, ranked #62.

Schonfeld Group Holdings first reported a position in BIIB in Q4 2013 and has held it in 4 quarters since. The position peaked at $1.44M in Q1 2014. 969 funds tracked by Wall St. Rank hold BIIB as of Q4 2015.

  • Schonfeld Group Holdings held 2,334 shares of Biogen worth $715K as of Q4 2015.
  • Schonfeld Group Holdings bought 834 Biogen shares in Q4 2015, an estimated $240K.
  • Biogen made up 0.45% of Schonfeld Group Holdings's portfolio in Q4 2015, its #62 holding.
  • Schonfeld Group Holdings first reported a position in Biogen in Q4 2013 and has held it in 4 quarters since.
  • Schonfeld Group Holdings's Biogen position peaked at $1.44M in Q1 2014.
  • 969 funds tracked by Wall St. Rank held Biogen as of Q4 2015.

Based on Schonfeld Group Holdings's 13F filing for Q4 2015, filed 12 Feb 2016.